# Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial

> **NCT00578617** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 60 (actual)

## Conditions studied

- Atrial Fibrillation
- Arrhythmia

## Interventions

- **DRUG:** Rate Control
- **DEVICE:** Ablation Therapy
- **DRUG:** Rate Control
- **DRUG:** Rate control
- **DRUG:** Rate control
- **DRUG:** Rate control
- **DRUG:** Rate Control
- **DRUG:** Rate Control
- **DRUG:** Rate Control
- **DRUG:** Rhythm Control
- **DRUG:** Rhythm control
- **DRUG:** Rhythm control
- **DRUG:** Rhythm control
- **DRUG:** Rhythm control
- **DRUG:** Rhythm control

## Key facts

- **NCT ID:** NCT00578617
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2009-02
- **Final completion:** 2010-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2013-01-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00578617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00578617, "Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT00578617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
